Cargando…
Efficient Secretion of Murine IL-2 From an Attenuated Strain of Clostridium sporogenes, a Novel Delivery Vehicle for Cancer Immunotherapy
Despite a history dating back to the 1800s, using Clostridium bacteria to treat cancer has not advanced beyond the observation that they can colonise and partially destroy solid tumours. Progress has been hampered by their inability to eradicate the viable portion of tumours, and an instinctive anxi...
Autores principales: | Kubiak, Aleksandra M., Bailey, Tom S., Dubois, Ludwig J., Theys, Jan, Lambin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217651/ https://www.ncbi.nlm.nih.gov/pubmed/34168629 http://dx.doi.org/10.3389/fmicb.2021.669488 |
Ejemplares similares
-
Complete Genome Sequence of the Nonpathogenic Soil-Dwelling Bacterium Clostridium sporogenes Strain NCIMB 10696
por: Kubiak, Aleksandra M., et al.
Publicado: (2015) -
Refined control of CRISPR-Cas9 gene editing in Clostridium sporogenes: the creation of recombinant strains for therapeutic applications
por: Kubiak, Aleksandra M., et al.
Publicado: (2023) -
Clostridium sporogenes bacteremia in an immunocompetent patient
por: Abusnina, Waiel, et al.
Publicado: (2019) -
Bacteremia caused by Clostridium sporogenes in an oncological patient
por: Cobo, Fernando, et al.
Publicado: (2023) -
Susceptibility of Clostridium Sporogenes Spores to Selected Reference Substances and Disinfectants
por: Chojecka, Agnieszka
Publicado: (2022)